Marksans Pharma Limited has informed the Exchange about Schedule of meet
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has scheduled an earnings conference call for analysts and investors on Wednesday, August 13, 2025 at 4:00 PM IST. The call will discuss the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1FY26). The management will be represented by Founder/Chairman/MD Mark Saldanha and CFO Jitendra Sharma, with the call led by DAM Capital Advisors. The presentation, audio recording, and transcript will later be hosted on the company's website.
This is a routine regulatory intimation and does not have a direct material impact on the stock. Investors should watch the call for insights into Q1FY26 revenue, margins, and management outlook, which could influence sentiment ahead of and after the results.